Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors

Nature Medicine

Volumn 13, Issue 10, 2007, Pages 1211-1218

  Soucek, Laura ^a   Lawlor, Elizabeth R ^a,c   Soto, Darya ^b   Shchors, Ksenya ^a   Swigart, Lamorna Brown ^a   Evan, Gerard I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROMOGLYCATE DISODIUM; MYC PROTEIN; TAMOXIFEN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DEATH; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MAST CELL; MOUSE; NONHUMAN; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; TUMOR LOCALIZATION;

ANIMALS; BONE MARROW CELLS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL5; FEMUR; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 34948852371     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1649     Document Type: Article

References (41)

1. Dvorak, H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650-1659 (1986).
2. Balkwill, F. & Mantovani, A. Inflammation and cancer: back to Virchow? Lancet 357, 539-545 (2001).
3. Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364 (1996).
4. Griffioen, A.W. & Molema, G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol. Rev. 52, 237-268 (2000).
5. Bernardini, G. et al. Analysis of the role of chemokines in angiogenesis. J. Immunol. Methods 273, 83-101 (2003).
6. Vicari, A.P. & Caux, C. Chemokines in cancer. Cytokine Growth Factor Rev. 13, 143-154 (2002).
7. Pelengaris, S., Littlewood, T., Khan, M., Elia, G. & Evan, G. Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol. Cell 3, 565-577 (1999).
8. Pelengaris, S., Khan, M. & Evan, G.I. Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109, 321-334 (2002).
9. Shchors, K. et al. The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β. Genes Dev. 20, 2527-2538 (2006).
10. Lawlor, E.R. et al. Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis. Cancer Res. 66, 4591-4601 (2006).
11. Scapini, P. et al. CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. J. Immunol. 172, 5034-5040 (2004).
12. Michalec, L. et al. CCL7 and CXCL10 orchestrate oxidative stress-induced neutrophilic lung inflammation. J. Immunol. 168, 846-852 (2002).
13. Belo, A.V. et al. Murine chemokine CXCL2/KC is a surrogate marker for angiogenic activity in the inflammatory granulation tissue. Microcirculation 12, 597-606 (2005).
14. Amann, B., Perabo, F.G., Wirger, A., Hugenschmidt, H. & Schultze-Seemann, W. Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer. Br. J. Urol. 82, 118-121 (1998).
15. Fischer, M. et al. Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue. Int. J. Cancer 107, 197-201 (2003).
16. Robinson, S.C. & Coussens, L.M. Soluble mediators of inflammation during tumor development. Adv. Cancer Res. 93, 159-187 (2005).
17. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S. & Ruco, L. The origin and function of tumor-associated macrophages. Immunol. Today 13, 265-270 (1992).
18. Norrby, K. Mast cells and angiogenesis. APMIS 110, 355-371 (2002).
19. Kanbe, N. et al. Human mast cells produce matrix metalloproteinase 9. Eur. J. Immunol. 29, 2645-2649 (1999).
20. Toth, T., Toth-Jakatics, R., Jimi, S. & Takebayashi, S. Increased density of interstitial mast cells in amyloid A renal amyloidosis. Mod. Pathol. 13, 1020-1028 (2000).
21. Sawatsubashi, M. et al. Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch. 436, 243-248 (2000).
22. Coussens, L.M. et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13, 1382-1397 (1999).
23. Bergers, G. et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737-744 (2000).
24. Thompson, P.J., Hanson, J.M. & Morley, J. Asthma, mast cells, and sodium cromoglycate. Lancet 2, 848-849 (1983).
25. Nagle, D.L., Kozak, C.A., Mano, H., Chapman, V.M. & Bucan, M. Physical mapping of the Tec and Gabrb1 loci reveals that the Wsh mutation on mouse chromosome 5 is associated with an inversion. Hum. Mol. Genet. 4, 2073-2079 (1995).
26. W-sh sash mice. Clin. Exp. Allergy 35, 82-88 (2005).
27. W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167, 835-848 (2005).
28. Duttlinger, R. et al. W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis. Development 118, 705-717 (1993).
29. Bonner-Weir, S. Perspective: postnatal pancreatic beta cell growth. Endocrinology 141, 1926-1929 (2000).
30. Bonner-Weir, S. Life and death of the pancreatic beta cells. Trends Endocrinol. Metab. 11, 375-378 (2000).
31. Laybutt, D.R. et al. Overexpression of c-Myc in β-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression, and diabetes. Diabetes 51, 1793-1804 (2002).
32. Kaneto, H. et al. Induction of c-Myc expression suppresses insulin gene transcription by inhibiting NeuroD/BETA2-mediated transcriptional activation. J. Biol. Chem. 277, 12998-13006 (2002).
33. Folkman, J. Angiogenesis. Annu. Rev. Med. 57, 1-18 (2006).
34. Bot, I. et al. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation 115, 2516-2525 (2007).
35. Kopp, H.G., Ramos, C.A. & Rafii, S. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr. Opin. Hematol. 13, 175-181 (2006).
36. Rubin, B.P. et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res. 61, 8118-8121 (2001).
37. Hirota, S. et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279, 577-580 (1998).
38. Sperling, C., Schwartz, S., Buchner, T., Thiel, E. & Ludwig, W.D. Expression of the stem cell factor receptor C-KIT (CD117) in acute leukemias. Haematologica 82, 617-621 (1997).
39. Escribano, L., Ocqueteau, M., Almeida, J., Orfao, A. & San Miguel, J.F. Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis. Leuk. Lymphoma 30, 459-466 (1998).
40. Zhang, R. et al. Mob-1, a Ras target gene, is overexpressed in colorectal cancer. Oncogene 14, 1607-1610 (1997).
41. Borrello, M.G. et al. Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Proc. Natl. Acad. Sci. USA 102, 14825-14830 (2005).